Hormonal influences of early postnatal indomethacin and ibuprofen in neonatal rats

Growth Hormone and IGF Research

Volumn 20, Issue 1, 2010, Pages 31-38

  Gebrekristos, Bisrat ^a,b   Beharry, Kay D ^a,b   Brock, Romy S ^a   Kuniyoshi, Katherine ^a,b   Abad Santos, Patricia ^b   Abad Santos, Matthew ^b   Aranda, Jacob V ^c   Modanlou, Houchang D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MILLER CHILDREN S HOSPITAL   (United States)

^c CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

Author keywords

Corticosterone; Growth hormone; Growth hormone binding protein; Ibuprofen; Indomethacin; Insulin; Insulin like growth factor I

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE BINDING PROTEIN; IBUPROFEN LYSINE; INDOMETACIN; INSULIN; PROSTAGLANDIN; PROSTAGLANDIN INHIBITOR; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY GROWTH; BODY WEIGHT; CHEMICAL STRESS; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; ENZYME INHIBITION; GROWTH REGULATION; HORMONE ACTION; HORMONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSULIN BLOOD LEVEL; LIVER LEVEL; LIVER WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; REBOUND;

ANIMALS; ANIMALS, NEWBORN; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARRIER PROTEINS; CORTICOSTERONE; CYCLOOXYGENASE INHIBITORS; DUCTUS ARTERIOSUS, PATENT; GROWTH HORMONE; IBUPROFEN; INDOMETHACIN; INSULIN; INSULIN-LIKE GROWTH FACTOR I; PROSTAGLANDINS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 74649085524     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2009.07.002     Document Type: Article

References (54)

1. Malviya M., Ohlsson A., and Shah S.S. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants, Cochrane. Database. Syst. Rev. 1 (2008) CD003951
2. Clyman R.I., Brett C., and Mauray F. Circulating prostaglandin E2 concentrations and incidence of patent ductus arteriosus in preterm infants with respiratory distress syndrome. Pediatrics 66 (1980) 725-729
3. Patole S. Strategies for prevention of feed intolerance in preterm neonates: a systematic review. J. Matern. Fetal. Neonatal. Med. 18 (2005) 67-76
4. Smith W.L. The eicosanoids and their biochemical mechanisms of action. Biochem. J. 259 (1989) 315-324
5. Aprikian O., Reynaud D., Pace-Asciak C., et al. Neonatal dietary supplementation of arachidonic acid increases prostaglandin levels in adipose tissue but does not promote fat mass development in guinea pigs. Am. J. Physiol. Regul. Integr. Comp. Physiol. 293 (2007) R2006-R2012
6. Négrel R., Gaillard D., and Ailhaud G. Prostacyclin as a potent effector of adipose-cell differentiation. Biochem. J. 257 (1989) 399-405
7. Gaillard D., Négrel R., Lagarde M., and Ailhaud G. Requirement and role of arachidonic acid in the differentiation of pre-adipose cells. Biochem. J. 257 (1989) 389-397
8. Chiesa C., Osborn J.F., Haass C., et al. Ghrelin, Leptin, IGF-1, IGFBP-3, and insulin concentrations at birth: is there a relationship with fetal growth and neonatal anthropometry?. Clin. Chem. 54 (2008) 550-558
9. Guan Z., Buckman S.Y., Baier L.D., and Morrison A.R. IGF-I and insulin amplify IL-1 beta-induced nitric oxide and prostaglandin biosynthesis. Am. J. Physiol. 274 (1998) F673-679
10. Tahara K., Grollman E.F., Saji M., and Kohn L.D. Regulation of prostaglandin synthesis by thyrotropin, insulin or insulin-like growth factor-I, and serum in FRTL-5 rat thyroid cells. J. Biol. Chem. 266 (1991) 440-448
11. 2α. J. Anim. Sci. 49 (1979) 1517-1521
12. MacLeod R.M., and Lehmeyer J.E. Release of pituitary growth hormone by prostaglandins and dibutyryl adenosine cyclic 3′,5′-monophosphate in the absence of protein synthesis. Proc. Natl. Acad. Sci. USA 67 (1970) 1172-1179
13. Miceli F., Tropea A., Minici F., et al. Effects of insulin-like growth factor I and II on prostaglandin synthesis and plasminogen activator activity in human umbilical vein endothelial cells. J. Clin. Endocrinol. Metab. 90 (2005) 372-378
14. 2 synthesis by human corpus luteum in vitro: a possible balance of luteotropic and luteolytic effects. J. Clin. Endocrinol. Metab. 84 (1999) 2507-2512
15. Pash J.M., Delany A.M., Adamo M.L., Roberts Jr. C.T., LeRoith D., and Canalis E. Regulation of insulin-like growth factor I transcription by prostaglandin E2 in osteoblast cells. Endocrinology 136 (1995) 33-38
16. Bichell D.P., Rotwein P., and McCarthy T.L. Prostaglandin E2 rapidly stimulates insulin-like growth factor-I gene expression in primary rat osteoblast cultures: evidence for transcriptional control. Endocrinology 133 (1993) 1020-1028
17. Hanna C.E., Keith L.D., Colasurdo M.A., et al. Hypothalamic pituitary adrenal function in the extremely low birth weight infant. J. Clin. Endocrinol. Metab. 76 (1993) 384-387
18. Bernardini R., Chiarenza A., Calogero A.E., Gold P.W., and Chrousos G.P. Arachidonic acid metabolites modulate rat hypothalamic corticotropin-releasing hormone secretion in vitro. Neuroendocrinology 50 (1989) 708-715
19. Bugajski A.J., Gadek-Michalska A., and Bugajski J. The involvement of nitric oxide and prostaglandins in the cholinergic stimulation of hypothalamic-pituitary-adrenal response during crowding stress. J. Physiol. Pharmacol. 57 (2006) 463-477
20. Bugajski J., Gadek-Michalska A., and Bugajski A.J. Nitric oxide and prostaglandin systems in the stimulation of hypothalamic-pituitary-adrenal axis by neurotransmitters and neurohormones. J. Physiol. Pharmacol. 55 (2004) 679-703
21. Cavagnini F., Di Lando A., Invitti C., et al. Effects of acetylsalicylic acid and indomethacin on growth hormone secretion in man. Metabolism 26 (1977) 193-200
22. Di Luigi L., Rossi C., Sgro P., et al. Do non-steroidal anti-inflammatory drug influence the steroid hormone milieu in male athletes?. Int. J. Sport. Med. 28 (2007) 809-814
23. Herrera C., Holberton J., and Davis P. Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants, Cochrane. Database. Syst. Rev. 2 (2007) CD003480
24. Krasna I.H., and Kim H. Indomethacin administration after temporary ischemia causes bowel necrosis in mice. J. Pediatr. Surg. 27 (1992) 805-8077
25. Pietz J., Achanti B., Lilien L., Stepka E.C., and Mehta S.K. Prevention of necrotizing enterocolitis in preterm infants: a 20-year experience. Pediatrics 119 (2007) e164-e170
26. Tatli M.M., Kumral A., Duman N., Demir K., Gurcu O., and Ozkan H. Spontaneous intestinal perforation after oral ibuprofen treatment of patent ductus arteriosus in two very-low-birthweight infants. Acta Paediatr. 93 (2004) 999-1001
27. Giacoia G.P., Azubuike K., and Taylor J.R. Indomethacin and recurrent ileal perforations in a preterm infant. J. Perinatol. 13 (1993) 297-299
28. Ohlsson A., Walia R., and Shah S. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants, Cochrane. Database. Syst. Rev. 4 (2005) CD003481
29. Sullivan M.C., Hawes K., Winchester S.B., and Miller R.J. Developmental origins theory from prematurity to adult disease. J.O.G.N.N. 37 (2008) 158-164
30. Holsti L., Weinberg J., Whitfield M.F., and Grunau R.E. Relationships between adrenocorticotropic hormone and cortisol are altered during clustered nursing care in preterm infants born at extremely low gestational age. Early. Hum. Dev. 83 (2007) 341-348
31. Fisher D.A. The unique endocrine milieu of the fetus. J. Clin. Invest. 78 (1986) 603-611
32. Watanabe T., Morimoto A., Morimoto K., Nakamori T., and Murakami N. ACTH release induced in rats by noradrenaline is mediated by prostaglandin E2. J. Physiol. 443 (1991) 431-439
33. Watanabe T., Morimoto A., Sakata Y., and Murakami N. ACTH response induced by interleukin-1 is mediated by CRF secretion stimulated by hypothalamic PGE. Experientia 46 (1990) 481-484
34. Murphy B.E. Human fetal serum cortisol levels related to gestational age: evidence of a mid gestational fall and a steep late gestational rise, independent of sex or mode of delivery. Am. J. Obstet. Gynecol. 144 (1982) 276-282
35. Kitterman J.A., Liggins G.C., Campos G.A., et al. Prepartum maturation of the lung in fetal sheep: relation to cortisol. J. Appl. Physiol. 51 (1981) 384-390
36. Devaskar S.U., Ganguli S., Devaskar U.P., and Sperling M.A. Glucocorticoids and hypothyroidism modulate development of fetal lung insulin receptors. Am. J. Physiol. 242 (1982) E384-E391
37. Clyman R.I., Mauray F., Roman C., Rudolph A.M., and Heymann M.A. Glucocorticoids alter the sensitivity of the lamb ductus arteriosus to prostaglandin E2. J. Pediatr. 98 (1981) 126-128
38. Corssmit E.P., Romijn J.A., Endert E., and Sauerwein H.P. Indomethacin stimulates basal glucose production in humans without changes in concentrations of glucoregulatory hormones. Clin. Sci. (Lond). 85 (1993) 679-685
39. Bauer M.K., Breier B.B., Bloomfield F.H., Jensen E.C., Gluckman P.D., and Harding J.E. Chronic pulsatile infusion of growth hormone to growth-restricted fetal sheep increases circulating fetal insulin-like growth factor-I levels but not fetal growth. J. Endocrinol. 177 (2003) 83-92
40. Harada I., Tsutsumi O., Momoeda M., et al. Comparative concentrations of growth hormone-binding protein in maternal circulation, fetal circulation, and amniotic fluid. Endocr. J. 44 (1997) 111-116
41. Tiong T.S., and Herington A.C. Ontogeny of messenger RNA for the rat growth hormone receptor and serum binding protein. Mol. Cell. Endocrinol. 83 (1992) 133-141
42. Fontoura M., Hocquette J.F., Clot J.P., et al. Regulation of the growth hormone binding proteins in human plasma. Acta. Endocrinol. (Copenh). 124 (1991) 10-13
43. Schmitt J.K. Indomethacin increases plasma growth hormone levels in man. Am. J. Med. Sci. 300 (1990) 144-147
44. Cavagnini F., Di Landro A., Invitti C., et al. Effects of acetylsalicylic acid and indomethacin on growth hormone secretion in man. Metabolism 26 (1977) 193-200
45. Schmitt J.K. Ibuprofen fails to increase plasma growth hormone levels in humans. Am. J. Med. Sci. 305 (1993) 289-291
46. Kirtikara K., Swangkul S., and Ballou L.R. The analysis of nonsteroidal antiinflammatory drug selectivity in prostaglandin G/H (PGHS)-null cells. Inflamm. Res. 50 (2001) 327-332
47. Uzan A. The unexpected side effects of new nonsteroidal anti-inflammatory. Expert Opin. Emerg. Drug. 10 (2005) 687-688
48. Talamantes F., and Ortiz R. Structure and regulation of expression of the mouse GH receptor. J. Endocrinol. 175 (2002) 55-59
49. Baumann G. Growth hormone binding protein. The soluble growth hormone receptor. Minerva. Endocrinol. 27 (2002) 265-276
50. Amit T., Youdim M.B., and Hochberg Z. Does serum growth hormone (GH) binding protein reflect human GH receptor function?. J. Clin. Endocrinol. Metab. 85 (2000) 927-932
51. Phornphutkul C., Frick G.P., Goodman H.M., Berry S.A., and Gruppuso P.A. Hepatic growth hormone signaling in the late gestation fetal rat. Endocrinology 141 (2000) 3227-3533
52. Li J., Owens J.A., Owens P.C., Saunders J.C., Fowden A.L., and Gilmour R.S. The ontogeny of hepatic growth hormone receptor and insulin-like growth factor I gene expression in the sheep fetus during late gestation: developmental regulation by cortisol. Endocrinology 137 (1996) 1650-1657
53. Beharry K.D., Modanlou H.D., Hasan J., et al. Comparative effects of early postnatal ibuprofen and indomethacin on VEGF, IGF-I, and GH during rat ocular development. Invest. Ophthalmol. Vis. Sci. 47 (2006) 3036-3043
54. Granado M., Martín A.I., Villanúa M.A., and López-Calderón A. Experimental arthritis inhibits the insulin-like growth factor-I axis and induces muscle wasting through cyclooxygenase-2 activation. Am. J. Physiol. Endocrinol. Metab. 292 (2007) E1656-E1665